Enabling lung disease patients to be treated at the earliest stage and cured
Optellum has developed the world’s first AI-based Decision Support software to enable physicians to manage lung nodule patients optimally.
Our platform helps clinicians identify and track at-risk patients and speed up decisions for those with cancer while reducing unnecessary procedures.
WHAT WE DO
We are developing an Artificial Intelligence software platform to support clinicians in lung cancer nodule management.
WHO WE ARE
A team of award-winning machine learning, medical device and clinical experts who work with top hospitals, physicians and authors of lung cancer guidelines across Europe and US.
HOW WE DO IT
Optellum and partners have gathered the largest real-world dataset and from this, using Artificial Intelligence and Machine Learning, have developed a solution to enable clinicians to identify at-risk patients and to guide lung cancer management.
AI aids classification of indeterminate lung nodules
Global leading doctors from Oxford and Vanderbilt, published independent clinical validation of Optellum Lung Cancer Prediction AI in the "Blue Journal", the leading publication in.
New Appointments Strengthen Leadership Team
Optellum has strengthened leadership team to support the commercialisation and clinical validation of its first product, and the development of product pipeline in the treatment.